Lake Oswego, OR, United States of America

Wassana Yantasee

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Wassana Yantasee - Pioneer in Cancer Treatment Therapies

Introduction:

Wassana Yantasee, a highly accomplished inventor based in Lake Oswego, Oregon, stands out as a leading figure in the field of cancer treatment innovations. With an impressive track record of 6 patents to her name, Yantasee's groundbreaking work revolves around therapeutic constructs for the co-delivery of mitotic kinase inhibitors and immune checkpoint inhibitors.

Latest Patents:

Yantasee's most recent patents demonstrate her dedication to developing cutting-edge solutions in cancer therapy. The therapeutic constructs she has designed involve a sophisticated interplay between delivery particles, mitotic kinase inhibitors, immune checkpoint inhibitors, and chemical linkers. These constructs have shown significant potential in enhancing the therapeutic index of free drugs, enabling targeted delivery of therapeutics, and inducing cancer cell death through a combination of therapeutic and immune effects.

Career Highlights:

Throughout her career, Wassana Yantasee has made substantial contributions to the field of oncology. Her work at Oregon Health & Science University and Pdx Pharmaceuticals, Inc. has been instrumental in advancing the boundaries of cancer treatment methodologies. Yantasee's dedication to improving patient outcomes and revolutionizing cancer therapeutics has earned her a reputation as a trailblazer in the industry.

Collaborations:

In her pursuit of innovation, Wassana Yantasee has collaborated closely with accomplished individuals in the field. Notable colleagues such as Worapol Ngamcherdtrakul and Moataz Reda have worked alongside Yantasee, collectively driving forward the development of novel therapeutic approaches for combating various types of cancer. Through synergistic teamwork and shared expertise, Yantasee and her collaborators have propelled the field of oncological research to new heights.

Conclusion:

In conclusion, Wassana Yantasee's pioneering work in cancer treatment therapies underscores her unwavering commitment to advancing the field of oncology. With a rich tapestry of patents, a distinguished career history, and impactful collaborations, Yantasee continues to shape the landscape of cancer therapeutics with her innovative solutions. Her dedication to harnessing the power of science for the betterment of patient lives is a testament to her status as a visionary inventor in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…